Literature DB >> 29617735

Direct-Acting Antivirals and Hepatitis C: The Ethics of Price and Rationing by Genotype.

Alexis Walker1, Angie Boyce1, Gail Geller1, Chloe L Thio2, Jeffrey P Kahn1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29617735      PMCID： PMC7190899          DOI： 10.1093/cid/ciy239

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  4 in total

1.  Incidence, risk factors, and prevention of hepatitis C reinfection: a population-based cohort study.

Authors:  Nazrul Islam; Mel Krajden; Jean Shoveller; Paul Gustafson; Mark Gilbert; Jane A Buxton; Jason Wong; Mark W Tyndall; Naveed Zafar Janjua
Journal:  Lancet Gastroenterol Hepatol       Date:  2016-12-23

2.  Pharmaceutical research and development: what do we get for all that money?

Authors:  Donald W Light; Joel R Lexchin
Journal:  BMJ       Date:  2012-08-07

3.  On the potential of a short-term intensive intervention to interrupt HCV transmission in HIV-positive men who have sex with men: A mathematical modelling study.

Authors:  L Salazar-Vizcaya; R D Kouyos; J Fehr; D Braun; J Estill; E Bernasconi; J Delaloye; M Stöckle; P Schmid; M Rougemont; G Wandeler; H F Günthard; O Keiser; A Rauch
Journal:  J Viral Hepat       Date:  2017-08-23       Impact factor: 3.728

4.  Spontaneous Viral Load Decline and Subsequent Clearance of Chronic Hepatitis C Virus in Postpartum Women Correlates With Favorable Interleukin-28B Gene Allele.

Authors:  Mohamed Hashem; Ravi Jhaveri; Doa'a A Saleh; Sahar A Sharaf; Fatma El-Mougy; Lobna Abdelsalam; Michelle D Shardell; Hesham El-Ghazaly; Samer S El-Kamary
Journal:  Clin Infect Dis       Date:  2017-09-15       Impact factor: 9.079
  4 in total
  1 in total

1.  Genomics in the era of COVID-19: ethical implications for clinical practice and public health.

Authors:  Gail Geller; Priya Duggal; Chloe L Thio; Debra Mathews; Jeffrey P Kahn; Lisa L Maragakis; Brian T Garibaldi
Journal:  Genome Med       Date:  2020-11-09       Impact factor: 11.117
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.